Form CORRESP - Correspondence:
SEC Accession No. 0001641172-25-006249
Filing Date
2025-04-25
Accepted
2025-04-25 16:52:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9862
  Complete submission text file 0001641172-25-006249.txt   11125
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)